Dr. Youhua Jiang 蒋友华
Chief Physician
Department of Esophageal (Mediastinal) Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of thoracic and abdominal tumors, with a focus on minimally invasive thoracoscopic and laparoscopic techniques for esophageal cancer, gastric cancer, lung cancer, and mediastinal tumors.
Dr. Jiang is a Chief Physician at Zhejiang Cancer Hospital in the Department of Esophageal (Mediastinal) Surgery. Dr. Jiang holds a bachelor's degree and specializes in the surgical and comprehensive treatment of thoracic and abdominal tumors.
Name order: in Chinese the family name comes first (Jiang Youhua). Papers usually list the name as Youhua Jiang or Jiang Y.
Selected publications
50 papers on PubMed matched by name and affiliation; 9 as first or senior author since 2016. Most recent first- or senior-author papers:
- Br J Radiol, 2026 (senior author): Variational autoencoder-based deep learning and radiomics for predicting pathologic complete response to neoadjuvant chemoimmunotherapy in locally advanced oesophageal squamous cell carcinoma. PubMed 40996309
- Bioengineered, 2021 (senior author): Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. PubMed 34346845
- Ann Transl Med, 2021 (senior author): The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer. PubMed 33850883
- J Thorac Dis, 2021 (senior author): Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma. PubMed 33841966
- J Gastrointest Oncol, 2021 (senior author): The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma. PubMed 33708420
- Front Oncol, 2020 (senior author): Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma. PubMed 33505917
- Cancer Manag Res, 2019 (senior author): Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma. PubMed 31447584
- Iran J Public Health, 2019 (first author): The Effects of Serum hs-CRP on the Incidence of Lung Cancer in Male Patients with Pulmonary Tuberculosis. PubMed 31497547
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion